Page last updated: 2024-09-04

mdl 74156 and aprepitant

mdl 74156 has been researched along with aprepitant in 1 studies

Compound Research Comparison

Studies
(mdl 74156)
Trials
(mdl 74156)
Recent Studies (post-2010)
(mdl 74156)
Studies
(aprepitant)
Trials
(aprepitant)
Recent Studies (post-2010) (aprepitant)
1452769229521

Protein Interaction Comparison

ProteinTaxonomymdl 74156 (IC50)aprepitant (IC50)
Cytochrome P450 3A4Homo sapiens (human)0.046
Substance-P receptorHomo sapiens (human)0.0002
Substance-P receptorMeriones unguiculatus (Mongolian gerbil)0.0001

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ahmed, T; Li, SX; Lupinacci, P; Majumdar, A; Murphy, MG; Panebianco, D; Pequignot, E; Petty, KJ; Rosen, L; Royalty, JE; Rushmore, TH1

Trials

1 trial(s) available for mdl 74156 and aprepitant

ArticleYear
Lack of effect of aprepitant on hydrodolasetron pharmacokinetics in CYP2D6 extensive and poor metabolizers.
    Journal of clinical pharmacology, 2006, Volume: 46, Issue:7

    Topics: Administration, Oral; Adult; Antiemetics; Aprepitant; Cross-Over Studies; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Electrocardiography; Enzyme Inhibitors; Female; Genotype; Humans; Indoles; Male; Middle Aged; Morpholines; Quinolizines; Reference Values; Serotonin Antagonists

2006